These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A comprehensive analysis of candidate genes in familial pancreatic cancer families reveals a high frequency of potentially pathogenic germline variants. Earl J; Galindo-Pumariño C; Encinas J; Barreto E; Castillo ME; Pachón V; Ferreiro R; Rodríguez-Garrote M; González-Martínez S; Ramon Y Cajal T; Diaz LR; Chirivella-Gonzalez I; Rodriguez M; de Castro EM; García-Seisdedos D; Muñoz G; Rosa JMR; Marquez M; Malats N; Carrato A EBioMedicine; 2020 Mar; 53():102675. PubMed ID: 32113160 [TBL] [Abstract][Full Text] [Related]
25. Hereditary and Sporadic Pancreatic Ductal Adenocarcinoma: Current Update on Genetics and Imaging. Morani AC; Hanafy AK; Ramani NS; Katabathina VS; Yedururi S; Dasyam AK; Prasad SR Radiol Imaging Cancer; 2020 Mar; 2(2):e190020. PubMed ID: 33778702 [TBL] [Abstract][Full Text] [Related]
26. Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters. Urayama S World J Gastroenterol; 2015 Feb; 21(6):1707-17. PubMed ID: 25684935 [TBL] [Abstract][Full Text] [Related]
27. Genomic Features and Clinical Management of Patients with Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer. Ohmoto A; Yachida S; Morizane C Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30699894 [TBL] [Abstract][Full Text] [Related]
29. Response assessment in pancreatic ductal adenocarcinoma: role of imaging. Baliyan V; Kordbacheh H; Parakh A; Kambadakone A Abdom Radiol (NY); 2018 Feb; 43(2):435-444. PubMed ID: 29243123 [TBL] [Abstract][Full Text] [Related]
30. Familial Pancreatic Cancer. Benzel J; Fendrich V Oncol Res Treat; 2018; 41(10):611-618. PubMed ID: 30269130 [TBL] [Abstract][Full Text] [Related]
31. Toward a better understanding of pancreatic ductal adenocarcinoma: glimmers of hope? Partensky C Pancreas; 2013 Jul; 42(5):729-39. PubMed ID: 23648843 [TBL] [Abstract][Full Text] [Related]
32. Familial Pancreatic Cancer and Surveillance of High-Risk Individuals. Matsubayashi H; Takaori K; Morizane C; Kiyozumi Y Gut Liver; 2019 Sep; 13(5):498-505. PubMed ID: 30917631 [TBL] [Abstract][Full Text] [Related]
33. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma. Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360 [TBL] [Abstract][Full Text] [Related]
34. The best linear unbiased prediction (BLUP) method as a tool to estimate the lifetime risk of pancreatic ductal adenocarcinoma in high-risk individuals with no known pathogenic germline variants. Cristina-Marianini-Rios ; Sanchez MEC; de Paredes AGG; Rodríguez M; Barreto E; López JV; Fuentes R; Beltrán MM; Sanjuanbenito A; Lobo E; Caminoa A; Ruz-Caracuel I; Durán SL; Olcina JRF; Blázquez J; Sequeros EV; Carrato A; Ávila JCM; Earl J Fam Cancer; 2024 Aug; 23(3):233-246. PubMed ID: 38780705 [TBL] [Abstract][Full Text] [Related]
35. Current Approaches to Pancreatic Cancer Screening. Chhoda A; Lu L; Clerkin BM; Risch H; Farrell JJ Am J Pathol; 2019 Jan; 189(1):22-35. PubMed ID: 30558719 [TBL] [Abstract][Full Text] [Related]
36. Familial pancreatic adenocarcinoma: A retrospective analysis of germline genetic testing in a French multicentre cohort. Schwartz M; Korenbaum C; Benfoda M; Mary M; Colas C; Coulet F; Parrin M; Jonveaux P; Ingster O; Granier S; De Mestier L; Cros J; Riffault A; Muller M; Levy P; Rebours V; Greenhalf W; Soufir N; Hammel P Clin Genet; 2019 Dec; 96(6):579-584. PubMed ID: 31432501 [TBL] [Abstract][Full Text] [Related]
37. High Growth Rate of Pancreatic Ductal Adenocarcinoma in Ibrahim IS; Wasser MN; Wu Y; Inderson A; de Vos Tot Nederveen Cappel WH; Morreau H; Hes FJ; Veenendaal RA; Putter H; Feshtali S; van Mil AM; Gruis NA; Tollenaar RA; Bergman W; Bonsing BA; Vasen HFA Cancer Prev Res (Phila); 2018 Sep; 11(9):551-556. PubMed ID: 29991580 [No Abstract] [Full Text] [Related]
38. Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment. Peters ML; Tseng JF; Miksad RA Clin Ther; 2016 Jul; 38(7):1622-35. PubMed ID: 27041411 [TBL] [Abstract][Full Text] [Related]
39. Pancreatic Cancer Surveillance and Novel Strategies for Screening. Dudley B; Brand RE Gastrointest Endosc Clin N Am; 2022 Jan; 32(1):13-25. PubMed ID: 34798981 [TBL] [Abstract][Full Text] [Related]
40. Imaging and targeted therapy of pancreatic ductal adenocarcinoma using the theranostic sodium iodide symporter (NIS) gene. Schmohl KA; Gupta A; Grünwald GK; Trajkovic-Arsic M; Klutz K; Braren R; Schwaiger M; Nelson PJ; Ogris M; Wagner E; Siveke JT; Spitzweg C Oncotarget; 2017 May; 8(20):33393-33404. PubMed ID: 28380420 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]